VERV - Verve Therapeutics, Inc.

QQQ $ 598.50 $ -4.01 (-0.67 %)

DIA $ 463.08 $ 2.03 (0.44 %)

SPY $ 662.74 $ -0.81 (-0.12 %)

TLT $ 90.69 $ 0.29 (0.32 %)

GLD $ 382.95 $ 2.70 (0.71 %)

Previous Close

$ 11.13

Open

$ 11.14

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

-- - --

52 Week Range

$ 2.86 - $ 11.41

Volume

10,306,656

Average Volume

Market Cap

992.16M

Beta (5Y Monthly)

$ 2.23

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-14-2025	03-31-2025	10-Q
2	02-27-2025	01-01-1970	10-K
3	11-05-2024	09-30-2024	10-Q
4	08-08-2024	06-30-2024	10-Q
5	05-08-2024	03-31-2024	10-Q
6	02-27-2024	12-31-2023	10-K
7	11-07-2023	09-30-2023	10-Q
8	08-10-2023	06-30-2023	10-Q
9	05-15-2023	03-31-2023	10-Q
10	03-02-2023	12-31-2022	10-K
11	11-07-2022	09-30-2022	10-Q
12	08-09-2022	06-30-2022	10-Q
13	05-10-2022	03-31-2022	10-Q
14	03-14-2022	12-31-2021	10-K
15	11-10-2021	09-30-2021	10-Q
16	08-12-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Eli Lilly And Verve Therapeutics Announces...
07/24/2025 12:05:51

Eli Lilly and Company (NYSE:LLY) and Verve Therapeutics, Inc. (NASDAQ:VERV) today announced that the tender offer to purchase a...

BMO Capital Downgrades Verve Therapeutics ...
06/27/2025 17:09:58

BMO Capital analyst Kostas Biliouris downgrades Verve Therapeutics (NASDAQ:VERV) from Outperform to Market Perform and lower...

eli-lillys-13-billion-verve-deal-signals-confidence-in-gene-editing-space-analyst

Eli Lilly's $1.3 Billion Verve Deal Signal...
06/18/2025 17:59:21

Lilly's Verve acquisition lifts sentiment in gene editing stocks, with analysts calling it a strategic and timely move in a...

this-verve-therapeutics-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-wednesday

This Verve Therapeutics Analyst Is No Long...
06/18/2025 12:34:59

HC Wainwright & Co. Downgrades Verve Thera...
06/18/2025 11:54:08

HC Wainwright & Co. analyst Mitchell Kapoor downgrades Verve Therapeutics (NASDAQ:VERV) from Buy to Neutral and maintain...

LifeSci Capital Downgrades Verve Therapeut...
06/18/2025 11:42:00

LifeSci Capital analyst Cory Jubinville downgrades Verve Therapeutics (NASDAQ:VERV) from Outperform to Market Perform and an...

Jefferies Downgrades Verve Therapeutics to...
06/18/2025 11:22:29

Jefferies analyst Roger Song downgrades Verve Therapeutics (NASDAQ:VERV) from Buy to Hold and lowers the price target from $...

5 Analysts Assess Verve Therapeutics: What...
06/17/2025 19:01:04

12 Health Care Stocks Moving In Tuesday's ...
06/17/2025 17:06:40

Jabil Posts Upbeat Earnings, Joins Verve T...
06/17/2025 15:03:06

William Blair Downgrades Verve Therapeutic...
06/17/2025 14:59:41

William Blair analyst Myles Minter downgrades Verve Therapeutics (NASDAQ:VERV) from Outperform to Market Perform.

Canaccord Genuity Downgrades Verve Therape...
06/17/2025 14:34:04

Canaccord Genuity analyst Whitney Ijem downgrades Verve Therapeutics (NASDAQ:VERV) from Buy to Hold and lowers the price tar...

top-3-health-care-stocks-that-are-ticking-portfolio-bombs

Top 3 Health Care Stocks That Are Ticking ...
06/17/2025 12:31:29

12 Health Care Stocks Moving In Tuesday's ...
06/17/2025 12:08:52

eli-lilly-expands-into-gene-editing-with-verve-therapeutics-acquisition

Eli Lilly Expands Into Gene Editing With V...
06/17/2025 12:07:25

Eli Lilly is acquiring Verve Therapeutics to strengthen its cardiovascular pipeline with a gene-editing drug targeting PCSK9-li...

Eli Lilly Agrees To Acquire Verve Therapeu...
06/17/2025 10:47:53

Verve's leading programs aim to deliver lifelong cardiovascular risk reduction with a single dose by targeting genes strong...

why-lennar-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Why Lennar Shares Are Trading Higher; Here...
06/17/2025 09:51:15

Verve Therapeutics Q1 EPS $(0.35) Versus $...
05/14/2025 11:07:47

Verve Therapeutics (NASDAQ:VERV) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(...

wolverine-world-wide-pacira-biosciences-and-other-big-stocks-moving-higher-on-monday

Wolverine World Wide, Pacira BioSciences A...
04/21/2025 14:36:15

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
04/15/2025 17:05:47